细胞外对比剂增强MRI联合扩散加权成像诊断HCC:与钆塞酸二钠增强MRI基于LI-RADS的前瞻性比较
这项前瞻性个体内比较研究纳入122例HCC高危患者共147个病灶,比较细胞外对比剂(ECA)MRI与钆塞酸二钠(HBA)MRI按LI-RADS v2018诊断HCC的表现。将DWI高信号作为主要特征加入ECA-MRI的改良LI-RADS,其敏感度和准确度均高于HBA-MRI的改良LI-RADS,特异度差异未达统计学显著。
要点
- 在ECA-MRI上把病灶扩散受限(DWI高信号)作为LI-RADS v2018主要特征,可提高LR-5诊断HCC的敏感度和准确度。
- 改良LI-RADS ECA-MRI的敏感度和准确度高于改良LI-RADS HBA-MRI,特异度差异未达统计学显著。
- 改良LI-RADS ECA-MRI特异度略低于两种常规标准,但差异无统计学意义。
核心结论
- 在ECA-MRI上以DWI表现作为改良LR-5的主要特征,诊断HCC的敏感度和准确度优于HBA-MRI上的改良LR-5,且与常规LR-5(ECA-MRI或HBA-MRI)相比特异度无显著降低。
研究设计与样本
- 前瞻性个体内比较研究,在一家三级转诊学术中心进行,纳入122例拟行肝脏手术的HCC高危患者共147个观察病灶,比较两种对比剂(细胞外对比剂ECA与肝胆特异性对比剂钆塞酸二钠HBA)肝脏MRI。
诊断标准与关键数值
- 改良LI-RADS在ECA-MRI上将DWI高信号作为主要特征,在HBA-MRI上将移行期(TP)和/或肝胆期(HBP)低信号作为廓清表现。
- 改良LI-RADS ECA-MRI诊断HCC的敏感度90.3%、准确度91.9%、特异度96.0%。
- 改良LI-RADS HBA-MRI诊断HCC的敏感度74.9%、准确度76.9%、特异度88.0%。
- 改良LI-RADS ECA-MRI敏感度(90.3% vs. 74.9%,p < 0.001)和准确度(91.9% vs. 76.9%,p < 0.001)高于改良LI-RADS HBA-MRI,特异度差异未达统计学显著(96.0% vs. 88.0%,p = 0.157)。
- 改良LI-RADS ECA-MRI特异度略低于两种常规标准,但差异无统计学意义(96.0% vs. 100%,p = 0.317)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: The aim of this study was to evaluate the diagnostic performance of introducing diffusion-weighted imaging (DWI) as a major feature to extracellular agent (ECA)-MRI for diagnosing HCC in comparison with gadoxetic acid (hepatobiliary agent, HBA)-MRI using Liver Imaging Reporting and Data System (LI-RADS) v2018.
METHODS: This was a prospective intra-individual comparison study using two different types of contrast agents for liver MRI conducted at a tertiary referral academic center. One hundred forty-seven observations in 122 patients at high risk for HCC scheduled for liver surgery were included. The sensitivity, specificity, and accuracy of LI-RADS category 5 (LR-5) for HCC diagnosis according to conventional and modified LI-RADS on ECA- and HBA-MRI were measured and compared. Modified LI-RADS incorporated hyperintensity on DWI as a major feature with ECA-MRI, and hypointensity on transitional phase (TP) and/or hepatobiliary phase (HBP) as washout appearance on HBA-MRI, respectively.
RESULTS: Modified LI-RADS on ECA-MRI had higher sensitivity and accuracy than modified LI-RADS on HBA-MRI (90.3% vs. 74.9%, p < 0.001; and 91.9% vs. 76.9%, p < 0.001, respectively), as well as higher specificity, although the difference did not reach statistical significance (96.0% vs. 88.0%, p = 0.157). The specificity of modified LI-RADS ECA-MRI was slightly lower than both conventional criteria but without a significant difference (96.0% vs. 100%, p = 0.317).
CONCLUSIONS: Using DWI findings as a major feature for modified LR-5 on ECA-MRI showed better sensitivity and accuracy than modified LR-5 on HBA-MRI, without significantly compromising specificity compared with conventional LR-5 on ECA- or HBA-MRI.
KEY POINTS: • Prospective intra-individual comparison study using two different types of contrast agents, extracellular agent (ECA) and gadoxetic acid (hepatobiliary agent, HBA), for liver MRI was conducted. • Applying diffusion restriction of a hepatic observation on ECA-MRI as a major feature of LI-RADS v2018 resulted in higher sensitivity and accuracy of LR-5 observations for HCC diagnosis than conventional LI-RADS v2018, and even compared to modified LI-RADS using modified washout on HBA-MRI. • Despite increase in sensitivity and accuracy of LR-5 observations on modified LI-RADS on ECA-MRI, the specificity was not significantly different compared with conventional LI-RADS.
引用
- Cha DI, Choi GS, Kim YK, et al. Extracellular contrast-enhanced MRI with diffusion-weighted imaging for HCC diagnosis: prospective comparison with gadoxetic acid using LI-RADS. Eur Radiol. 2020. PMID: 32128620. doi:10.1007/s00330-020-06753-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。